Europe's plan to restrict more than 10,000 per- and polyfluoroalkyl substances (PFAS) has cleared its scientific review and is entering the final stretch toward a European Commission proposal, Enhesa reported on Oct. 15.
ECHA's Committee for Risk Assessment (RAC) adopted its final opinion on March 2, 2026, concluding that PFAS pose an EU-wide risk that justifies restriction. RAC judged a full ban the most effective option and, on risk grounds alone, supported just one derogation: personal protective equipment that safeguards workers' health and safety.
ECHA's Committee for Socio-Economic Analysis (SEAC) took a more pragmatic line in its draft opinion, favoring a broad restriction with time-limited, use-specific derogations. The 60-day consultation on SEAC's draft closed on May 25, 2026, and its final opinion is expected before the end of 2026.
The restriction would prohibit the manufacture, use and placing on the market of PFAS above very low concentration limits, with RAC recommending thresholds of 25 ppb for any individual PFAS, 250 ppb for the sum of PFAS, and 50 ppm for total PFAS including polymers. The default transition period is 18 months.
On Sept. 17, 2026, EU Health Commissioner Olivér Várhelyi told the European Parliament that ECHA is in the final stages of its assessment. The Commission has said it intends to present its proposal rapidly once SEAC adopts its final opinion.
